DSCI Insider Trading Activity and SEC Form 4 Filings
DSCI insider trading summary
No open-market insider purchases or sales of Derma Sciences, Inc. (DSCI) have been reported on SEC Form 4 in the past 12 months.
Latest DSCI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 18, 2015 | Srini Conjeevaram | Director | Buy | $7K (1,100 @ $6.50) |
| Aug 14, 2015 | Stephen T Wills | Director | Buy | $20K (3,000 @ $6.59) |
| Aug 14, 2015 | Samuel E Navarro | Director | Buy | $8K (1,255 @ $6.49) |
| Aug 13, 2015 | Amy S Paul | Director | Buy | $33K (5,000 @ $6.61) |
| Aug 13, 2015 | Edward J Quilty | President & CEO | Buy | $100K (15,000 @ $6.65) |
| Aug 13, 2015 | Robert C Cole | See Remarks | Buy | $34K (5,000 @ $6.73) |
| Aug 13, 2015 | Stephen T Wills | Director | Buy | $45K (7,000 @ $6.39) |
| Aug 13, 2015 | Bruce F Wesson | Director | Buy | $66K (10,000 @ $6.58) |
| Aug 13, 2015 | Robert G Moussa | Director | Buy | $33K (5,000 @ $6.61) |
| Aug 13, 2015 | Samuel E Navarro | Director | Buy | $57K (8,745 @ $6.51) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.